Second Quarter 2022 Earnings Release Presentation July 21, 2022 Cautionary Statements 2 This presentation includes "forward-looking statements." These statements relate to future events, including, but not limited to, statements regarding our liquidity, operating results, future earnings, financial position, operational and strategic initiatives, and developments in legislation, regulation, and the healthcare industry more generally. These forward-looking statements represent management's expectations, base ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2022 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 _________________________________________ TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 95-25 ...

Tenet Healthcare Corporation (NYSE:THC) Q1 2022 Earnings Conference Call April 21, 2022 10:00 AM ET Company Participants Will McDowell - IR Dan Cancelmi - EVP & CFO Ron Rittenmeyer - Executive Chairman Saum Sutaria - CEO Conference Call Participants Josh Raskin - Nephron Research Justin Lake - Wolfe Research A.J. Rice - Credit Suisse Jamie Perse - Goldman Sachs Pito Chickering - Deutsche Bank Kevin Fischbeck - Bank of America Jason Cassorla - Citi Whit Mayo - SVB Leerink John Ransom - Raymond James Brian Ta ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K ý Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2021 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to (Registrant's telephone number, including area code) ________________________________________________________ Securities registered pursuant to Section 12( ...

| --- | --- | |-------|--------------------------------------| | | | | | Fourth Quarter 2021 Earnings Release | | | Presentation | | | February 7, 2022 | Cautionary Statements 2 This presentation includes "forward-looking statements." These statements relate to future events, including, but not limited to, statements regarding our liquidity, operating results, future earnings, financial position, operational and strategic initiatives, and developments in legislation, regulation, and the healthcare industry ...

Tenet Healthcare Corporation (NYSE:THC) Q4 2021 Earnings Conference Call February 8, 2022 10:00 AM ET Company Participants Dan Cancelmi - EVP & CFO Ron Rittenmeyer - Executive Chairman Saum Sutaria - CEO Brett Brodnax - President & CEO, USPI Conference Call Participants Kevin Fischbeck - Bank of America Pito Chickering - Deutsche Bank Sarah James - Barclays Justin Lake - Wolfe Research Josh Raskin - Nephron Research A.J. Rice - Credit Suisse Jason Cassorla - Citi Brian Tanquilut - Jefferies Ben Hendrix - RB ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2021 OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 _________________________________________ TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) ________ ...

Tenet Healthcare Corporation (NYSE:THC) Q3 2021 Earnings Conference Call October 21, 2021 10:00 AM ET Company Participants Regina Nethery - VP of IR Ron Rittenmeyer - Executive Chairman Saum Sutaria - CEO Dan Cancelmi - EVP and CFO Brett Brodnax - President and CEO, USPI Conference Call Participants Jamie Perse - Goldman Sachs A.J. Rice - Credit Suisse Brian Tanquilut - Jefferies Kevin Fischbeck - Bank of America Justin Lake - Wolfe Research Sarah James - Barclays Josh Raskin - Nephron Research Pito Chicker ...

| --- | --- | --- | |-------|------------------|-------------------------------------| | | | Third Quarter 2021 Earnings Release | | | Presentation | | | | October 20, 2021 | | Cautionary Statements This presentation includes "forward-looking statements." These statements relate to future events, including, but not limited to, statements regarding our liquidity, operating results, future earnings, financial position, operational and strategic initiatives, and developments in legislation, regulation, and the ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2021 OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 _________________________________________ TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) _____________ ...